# Study of the Efficacy and Safety of NST-1024 Versus Placebo in Subjects With Hypertriglyceridemia

> **NCT05889156** · PHASE2 · COMPLETED · sponsor: **NorthSea Therapeutics B.V.** · enrollment: 50 (actual)

## Conditions studied

- High Triglycerides

## Interventions

- **DRUG:** NST-1024
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05889156
- **Lead sponsor:** NorthSea Therapeutics B.V.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-30
- **Primary completion:** 2025-03-18
- **Final completion:** 2025-04-11
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2025-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05889156

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05889156, "Study of the Efficacy and Safety of NST-1024 Versus Placebo in Subjects With Hypertriglyceridemia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05889156. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*